Skip to main content
SpringerLink
Log in

ASO Author Reflections: Should We Be Using Dextrose-Containing Carrier Solutions for Perfusion During HIPEC?

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003; 21:3737–43.

    Article  PubMed  Google Scholar 

  2. Kusamura S, Dominique E, Baratti D, Younan R, Deraco M. Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2008; 98:247–252.

    Article  PubMed  Google Scholar 

  3. Kwon S, Thompson R, Dellinger P, Yanez D Farrohki E, Flum D. Importance of peri-operative glycemic control in general surgery: a report from the surgical care and outcomes assessment program. Ann Surg. 2013: 257:8–14.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Turaga K, Levine E, Barone R et al. Consensus guidelines from the American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Ann Surg Oncol. 2014; 21:1501–1505.

    Article  CAS  PubMed  Google Scholar 

  5. Stewart CL, Gleisner A, Halpern A, et al. Implications of hyperthermic intraperitoneal chemotherapy perfusion-related hyperglycemia. Ann Surg Oncol. 2018; 25:655–659.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, The University of Colorado School of Medicine, Aurora, CO, USA

    Camille L. Stewart MD & Martin McCarter MD

Authors
  1. Camille L. Stewart MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin McCarter MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Camille L. Stewart MD.

Ethics declarations

Disclosure

The authors have no conflicts of interest to disclose.

Additional information

This ASO Author Reflections is a brief invited commentary on the article “Implications of Hyperthermic Intraperitoneal Chemotherapy Perfusion-Related Hyperglycemia,” Ann Surg Oncol. 2018; 25:655–659.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stewart, C.L., McCarter, M. ASO Author Reflections: Should We Be Using Dextrose-Containing Carrier Solutions for Perfusion During HIPEC?. Ann Surg Oncol 25 (Suppl 3), 834–835 (2018). https://doi.org/10.1245/s10434-018-6794-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-018-6794-x

Keywords

Search

Navigation